104 related articles for article (PubMed ID: 14756543)
1. TP53 codon 72 polymorphism does not affect risk of cervical cancer in patients from The Gambia.
Tanara G; Falugi C; Cesario A; Margaritora S; Russo P; Cosimi A
Int J Biol Markers; 2003; 18(4):280-3. PubMed ID: 14756543
[TBL] [Abstract][Full Text] [Related]
2. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
3. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
6. P53 codon 72 polymorphism and human papillomavirus type in relation to cervical cancer in South African women.
Pegoraro RJ; Rom L; Lanning PA; Moodley M; Naiker S; Moodley J
Int J Gynecol Cancer; 2002; 12(4):383-8. PubMed ID: 12144687
[TBL] [Abstract][Full Text] [Related]
7. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
[TBL] [Abstract][Full Text] [Related]
8. p53 codon 72 polymorphism and its association with bladder cancer.
Soulitzis N; Sourvinos G; Dokianakis DN; Spandidos DA
Cancer Lett; 2002 May; 179(2):175-83. PubMed ID: 11888672
[TBL] [Abstract][Full Text] [Related]
9. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
11. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
[TBL] [Abstract][Full Text] [Related]
12. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women.
Bhattacharya P; Duttagupta C; Sengupta S
Cancer Lett; 2002 Dec; 188(1-2):207-11. PubMed ID: 12406566
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women.
El khair MM; Ennaji MM; El kebbaj R; Mhand RA; Attaleb M; El Mzibri M
Med Oncol; 2010 Sep; 27(3):861-6. PubMed ID: 19771536
[TBL] [Abstract][Full Text] [Related]
14. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
[TBL] [Abstract][Full Text] [Related]
15. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
16. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
[TBL] [Abstract][Full Text] [Related]
17. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
Tachezy R; Mikysková I; Saláková M; Van Ranst M
Hum Genet; 1999 Dec; 105(6):564-6. PubMed ID: 10647890
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.
Piña-Sánchez P; Hernández-Hernández DM; Taja-Chayeb L; Cerda-Flores RM; González-Herrera AL; Rodea-Avila C; Apresa-García T; Ostrosky-Wegman P; Vázquez-Ortíz G; Mendoza-Lorenzo P; Dueñas-González A; Salcedo M
Med Oncol; 2011 Dec; 28(4):1507-13. PubMed ID: 20661667
[TBL] [Abstract][Full Text] [Related]
19. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
[TBL] [Abstract][Full Text] [Related]
20. Lack of association between p53 codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections.
Rezza G; Giuliani M; Garbuglia AR; Serraino D; Cappiello G; Migliore G; Branca M; Benedetto A; Ippolito G
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):565-6. PubMed ID: 11352871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
